Market Overview

Lam Research On The Cusp Of Healthy Chip Industry Environment; Argus Initiates At Buy

Lam Research On The Cusp Of Healthy Chip Industry Environment; Argus Initiates At Buy

Argus initiated coverage of Lam Research Corporation (NASDAQ: LRCX) with a Buy rating and $196 price target for the shares, as it believes the company would benefit from demand growth for NAND and DRAM memory chips used in artificial intelligence, the Internet of Things, cloud computing and other emerging technologies.

Analysts Jim Kelleher and T.W. Smith said the company's etch and deposition tools are enabling vertical scaling, an innovative process in the production of semiconductor chips. With the impending end of Moore's law, the analysts noted that semiconductor companies are seeking to improve the performance of chips through vertical scaling.

Therefore, the analysts said Lam Research stands to benefit, as its products allow vertical scaling and other key technological advancements. Additionally, the analysts said the company is benefiting from particularly strong demand growth and pricing power in memory, the source of three-quarters of the company's system shipments in the fiscal year fourth quarter.

See also: All The AMD Launches Thus Far This Year

Argus noted that the company's fiscal year fourth-quarter earnings released in late July showed 52 percent year-over-year jump in revenues, widening margins and a 93-percent increase in non-GAAP earnings per share.

Argus also noted that unshipped orders in backlog were $2.1 billion at the end of fiscal year 2017, higher than $1.4 billion at the end of 2016, This, according to the firm, is reflective of the surging demand for the company's products.

On valuation, the firm noted that Lam Research shares were up 58 percent year to date compared to a 20-percent gain by the peer group of Argus semiconductor stocks and a 22-percent gain by the PHLX Semiconductor. This has come on top of the 37-percent gain in 2016.

Image Credit: By Lam Research - Aus englischer Wikipedia, Public Domain, via Wikimedia Commons

Latest Ratings for LRCX

Aug 2019MaintainsMarket Perform
Aug 2019MaintainsOverweight
Jul 2019UpgradesNeutralBuy

View More Analyst Ratings for LRCX
View the Latest Analyst Ratings

Posted-In: ArgusAnalyst Color Long Ideas Initiation Top Stories Analyst Ratings Tech Trading Ideas Best of Benzinga


Related Articles (LRCX)

View Comments and Join the Discussion!

Looking For Signs Of Life In Rite Aid Shares After Walgreens' Deal Disappointment

Procter & Gamble CEO: Nelson Peltz's Activist Campaign Is 'Very Dangerous'